Parallax Health Sciences Inc. executed an 8% Senior Secured Note in the principal sum of $220,000, pursuant to that certain Note and Purchase Agreement executed the same date. The Note bears interest at 8% per annum, and matures 180 days from the issuance date. As additional consideration for entering into the Purchase Agreement, 400,000 shares of the company’s restricted common stock is being issued to the note holder.